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In a previous communication (1) we have described the character- 
istic symptom-complex brought about by infecting rabbits intrader- 
really with Type I pneumococci.  The following paper is a continua- 
tion of that report. 
I. 
Specific  Serum  Therapy. 
Since we believe that  the rabbit  experiment as  described in  our 
first paper promises a method of determining the therapeutic potency 
of specific antipneumococcic serum more satisfactorily than the now 
prevalent mouse protection technic we have given considerable atten- 
tion to the effects of serum administration on the course of the pneu- 
mococcus infection of rabbits, both in regard to the local and general 
phenomena. 
The following points have already been established: 
1.  That animals recover promptly after the intravenous adminis- 
tration of large amounts of antipneumococcic serum. 
2.  That there are four important features of this induced recovery, 
as follow:  (a) the immediate and permanent disappearance of organ- 
isms from the circulating blood; (b) a drop in temperature to normal 
levels within 24 hours; (c) the disappearance of organisms from the 
local lesion in the course of 4 to 20 hours; (d) loss of inflBmmatory 
color of  the local lesion  within  24  hours, usually accompanied by 
epidermal desquamation. 
3.  That for a given serum at a given stage of the disease there may 
be  established  a  minimal  effective dosage (~r.E.D.) such that larger 
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amounts give no  added therapeutic value and  smaller amounts  are 
insufficient to bring about recovery. 
Minimal Effective Dosage at  Various Stages of the Disease.--It  is a 
common clinical observation that the amount of  serum which might 
be used effectively on the 1st or 2nd day of lobar pneumonia is insuffi- 
cient if given at a later time.  Some clinicians have even stated that 
after the infection has progressed beyond a certain point no amount of 
serum will save. 
The  question  of a  quantitative  element has  been  studied  in  the 
experimental "dermal pneumonia" of the rabbit by determining the 
minimal effective dose of a given serum for each of three stages of the 
disease.  It is necessary to stress again the sharpness of the end-point 
in determinations of the  effectiveness of therapeutic sera.  The re- 
sults of such an experiment are shown in Fig.  1. 
This  experiment shows that  the  amount  of  serum  necessary for 
effective therapy increases very rapidly as the disease progresses and 
emphasizes the importance of early treatment.  Even the time occu- 
pied in the ordinary typing process would greatly lessen or entirely 
eliminate the chances of successful therapy. 
For  this  particular  serum, if one assumed a  definite relationship 
between therapeutic dose and body weight of the animal and trans- 
ferred these proportions to man, the results would be as follow: In the 
standard rabbit  (1500  gin.) we have found it necessary to use serum 
to the amount of 0.23 per cent of body weight at 24 hours, 0.47 per 
cent at 48 hours, and approximately 0.67  per cent at 72 hours.  This 
would indicate that in a man of 70 kilos it would be necessary to use 
150 cc. of this serum at 24  hours, 325  cc.  at 48 hours, and approxi- 
mately 475  cc.  at  72  hours. 
In the experimental rabbit  condition it  is  not essential that  the 
minimal effective level be exceeded at a single injection but if multiple 
injections are used these must not be too far apart and the total quan- 
tity must exceed the minimal effective amount for that period.  Un- 
less  this  effective  level  is  exceeded at  a  given  time  absolutely  no 
beneficial result has been obtained. 
Bloomfield (2)  advances the opinion that in lobar pneumonia the 
usefulness of serum depends upon the presence and seriousness of the 
bacteriemia.  The rabbits which we have studied have shown some KENNETtt  GOODNER  415 
variation in the severity of the bacteriemia at the time of treatment 
but the minimal  effective dosage of the serum appears to  be a  fixed 
quantity for a  given period and this does not vary with the severity 
of the bacteriemia.  If such a  correlation did exist it might  be antici- 
pated that  ten times as much serum would be necessary at 48 hours 
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FIo. 1.  Determinations of  the minimal  effective dosage of Antipneumococcic 
Serum P 315 at various  stages of the disease.  The diagonal line represents  the 
suggested effective level of therapy. 
as was necessary at  24 hours,  for the number of bacteria  per cc. of 
blood has often increased by a multiple of 10 or even of 100. 
The contour of the suggested boundary curve, shown by the broken 
line in Fig. 1, suggests that there is a progressive rise in some element 
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antagonizes  it.  Proponents  of  the  pneumonia  toxin  theory  have 
advanced the idea that there may be a  progressive accumulation of 
some toxic element in the tissues. 
Decision as to the significance of the findings presented in Fig.  1 
must await the solution of this question.  Our results have shown, 
however, that there is an experimental basis  for early and vigorous 
treatment of lobar pneumonia, and would seem to point to  the im- 
mediate use of some sort of polyvalent serum, since the time required 
for  typing greatly  decreases  chances for  success  with  practicable 
amounts of serum. 
The  use  of  agglutinin  titer  or  protective value of a  specifically 
treated patient's serum in guiding further specific therapy has been 
suggested by  Sutliff  (3).  The  qualitative  detection of  agglutinins 
and protective substances in the treated rabbit indicates only that it 
has  been treated; even if  such tests  are  made  quantitatively the 
information gives only the approximate dilution that the therapeutic 
serum has undergone with the rabbit's own serum.  It is obvious that 
qualitative tests have little value since  various antibody levels  are 
necessary at  various  stages of the  disease  in order to  bring about 
successful therapy. 
The Comparison  and Standardization  of A ntipneumococcic  Sera  on 
the ~asis of Therapeutic  Value.--The earlier workers used agglutinin 
titer as  a  basis  for comparison of probable  therapeutic efficacy of 
sera.  This method has given way to a titration in which mouse pro- 
tection is the indicator of protective value.  The Hygienic Laboratory 
has established a certain standard and furnishes for comparative pur- 
poses a  serum which fulfills this requirement.  This standard is not 
based on any known quantitative therapeutic value for cases of lobar 
pneumonia. 
Having found the minimal effective dosage at a  given hour in a 
1500 gin. rabbit to be a characteristic of the serum and of a constant 
value for that serum, experiments were planned by which this might 
be made the basis  for the comparison of sera. 
Seven sera were selected for comparison.  The general plan of work 
consisted in  determining for each of the  sera the mouse-protective 
value,  the  agglutinin  titer,  and  the  therapeutic minimal  effective 
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In determining the mouse-protective value it was assumed that the so called 
virulence titer of a culture was in reality a measure of the number of minimal fatal 
doses of virulent pneumococci per cc. for mice.  The culture used had a virulence 
such that 0.000,000,1  cc. would cause the death of a mouse within 4 days.  With 
a definite dilution of this culture and varying quantities of the serum to be tested 
it was possible to arrive at a numerical value for the protective titer of each serum~ 
this protective value being defined as the number of mouse-protective units per cc, 
of undiluted serum.  The least amount of serum which will protect against a given 
dosage of pneumococci is determined.  By dividing this amount by the number of 
M.L.D. of pneumococci used, a figure is obtained which represents a unit of serum. 
The number of such units per cc. of serum constitutes the value which we use for 
comparison.  In every instance  except  one,  0.1  cc. of culture  (100,000  ~.L.D.) 
was employed against varying dilutions of serum.  The mouse-protective value 
which represents the minimal Hygienic Laboratory standard is 5~000,000, accord- 
ing to this system of calculation, but it will be seen that the serum furnished by 
them for comparison shows a much higher figure. 
The agglutinin titer was found by the ordinary technic, with heat-killed pneu- 
mococcus suspension as the agglutinogen. 
In determining the therapeutic value of each serum, rabbits were treated intra- 
venously at 24 hours following infective intradermal inoculation.  Careful studies 
such as detailed in the previous paper were made before and after treatment.  In 
order to determine  the approximate therapeutic zone a  preliminary experiment 
was carried out with widely varying amounts of serum.  Then a  second experi- 
ment was conducted in which the amounts were less widely separated.  The rab- 
bit therapeutic value is expressed in minimal effective doses per cc. of serum. 
The following sera were used for comparison. 
1.  Antipneumococcic serum (horse).  Hygienic Laboratory Control P 7. 
2. Antipneumococcic serum  (horse).  Massachusetts  Antitoxin  and  Vaccine 
Laboratory, Lot P  315.  This serum is of the  type with which  physicians  are 
supplied. 
3. Antipneumococcic serum  (horse).  Massachusetts  Antitoxin  and  Vaccine 
Laboratory, Lot 400-31.  An experimental serum prepared by the Zinsser-Grin- 
nell blood clot method (4). 
4. Antipneumococcic serum (horse).  Lot 440-3-I2.  An experimental serum: 
a bleeding at 6 days following a single injection of killed pneumococci. 
5.  Concentrated pneumococcus antibodies  (Felton).  Type I, Lot 56.  Sup- 
plied through the courtesy of Dr. L. Felton. 
6.  Serum from a  rabbit  which recovered without  treatment.  Bled 30  days 
after the infective inoculation (25 days after critical recovery).  Lot 296. 
7.  Serum of a  rabbit immunized by repeated injections of washed heat-killed 
pneumococci.  Lot 301. 
The results of the necessarily large number of experiments  are con- 
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The great interest in this table lies in the fact that the mouse-pro- 
tective doses listed in the column of mouse-protective values show the 
extraordinary potency of the serum in protecting a highly susceptible 
animal when serum and organisms are mixed before injection, an ex- 
perimental condition which is comparable in absolutely no respect to 
the condition under which the serum is therapeutically used.  In the 
second column under "Rabbit therapeutic value," also calculated for 
1 cc., is shown the much diminished potency, though still considerable, 
when the serum is used in another highly susceptible animal under 
conditions which,  we believe we are justified in  assuming,  simulate 
TABLE  I. 
Comparison  of Agglutinin  Titer, Mouse-Protective Value,  and Rabbit  Therapeutic 
Value of Seven Sera. 
Serum 
Mouse-protectlve  value 
(in terms of fatal doseE 
protected against by 1 
cc. of serum,  if  serur~ 
and  organisms  are 
mixed  in  vitro  before 
injection) 
500,000,000 
50,000,000 
50,000,000 
500,000 
1,428,000,000 
5,000,000 
50,000,0C0 
Rabbit therapeutic value 
Minimal effective dose 
of  serum  (amount 
necessary  to  bring 
about recovery  if ad- 
ministered  24  hrs. 
after infection) 
CC. 
3.0 
3.5 
3.5 
>  10.0 
0.2 
3.5 
0.5 
Minimal  effective 
doses  per  cc.  of 
serum 
0.33 
0.29 
0.29 
Less than 0.I 
5.0 
0.29 
2.0 
Agglutinin titer 
80 
40 
40 
0 
640 
10 
320 
the condition in man, under which serum is therapeutically employed, 
as closely as this can be done in animal experiments. 
It is not altogether surprising that there is not a complete parallel- 
ism between figures in the three columns but it is somewhat difficult 
to account for this in every case.  The first point that may well be 
considered is the therapeutic value of homologous as against heterolo- 
gous immune sera.  Nos.  6  and 7  are from rabbits,  and it  is to  be 
observed that these sera have a  low  mouse-protective value in com- 
parison with their relatively high therapeutic value for rabbits.  Thus, 
Serum 7 has only one-tenth the protective value of Serum 1, but  its KENNETH  GO  ODN-ER  419 
therapeutic value is six times greater.  Compared to Nos.  2  and 3, 
which have the same protective value, this serum has six or seven times 
the therapeutic value.  The same comparisons hold good for Serum 
6.  It is obvious that an homologous immune serum, although low in 
protective  value  for  an  heterologous  animal,  does  possess  marked 
therapeutic value as contrasted to the immune serum of a third species. 
The  cells of the treated  animal  are intimately concerned with  any 
change in the status of the disease and the homologous serum prob- 
ably owes its advantageous effect to the fact that  such proteins are 
more readily absorbed by the cells. 
A  consideration of the therapeutic value of the four more potent 
antisera from horses (Nos. 1, 2, 3, and 5)  shows that there is a more 
definite correlation with  the  agglutinin titer than  with the  mouse- 
protective value.  There is  a  very striking  dissimilarity in  relative 
mouse-protective and rabbit therapeutic values. 
It is suggested that a method of standardization of antipneumococcic 
serum, based on the rabbit therapeutic usage as outlined, might prove 
valuable  as  compared with the  present  system.  Such a  procedure 
would be no more difficult and only slightly more expensive than the 
mouse method and the results are quite as regular and definite.  It 
would have the great advantage of measuring that property for which 
the serum is utilized.  Our chief hesitancy in proposing such a method 
is that we do not know, nor is there any present method of determin- 
ing, whether the therapeutic value for rabbits does represent a definite 
measure of therapeutic value in human lobar pneumonia. 
II. 
Non-Specific Therapy. 
In many of these therapeutic experiments large amounts of foreign 
protein have been injected and it becomes important to separate the 
specific and non-specific effects.  To this end the latter type of ther- 
apy has been studied in sixteen cases with normal horse and rabbit 
sera and typhoid vaccine as the non-specific agents.  Various quanti- 
ties were employed and the  cases were usually treated at  24  hours 
following infection.  Four of this series of sixteen survived but this 
survival rate does not sufficiently exceed that  of untreated cases to 
be  considered significant. 420  INTRADEIIMAL  PIWEU~IOCOCCUS  INFECTION 
Following the intravenous  injection,  at 24 hours after infection, of 
3 to 5 cc. of normal horse serum the temperature may be slightly ele- 
vated for a few hours.  The number of white cells, already rather low, 
is not  appreciably  altered.  The  most  striking  result  that  has  been 
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FIo. 2.  Chart  of findings on Rabbit 3-71  showing the effects of the injection 
of a non-specific  agent. 
observed  is  the  immediate  disappearance  of pneumococci  from  the 
circulating blood.  The blood may remain free of organisms for several 
hours but the bacteria then reappear in increasing numbers.  A chart 
of such a  case is shown in Fig. 2. KENNETH  GO  ODIN-ER  421 
The normal horse serum used in these experiments had no protec- 
tive action against pneumococci in mice and the result of the treat- 
ment of these rabbits,  in so far as can be determined, must be due 
entirely to non-specific factors.  This conclusion is supported by the 
finding that the same result is obtained if typhoid vaccine is adminis- 
tered intravenously. 
It has been suggested that the immediate freeing of the blood stream 
of organisms in the specifically treated case may be due entirely to 
non-specific factors, but this is probably not the case.  That the spe- 
cific element alone is capable of bringing about this effect is shown in 
instances  of  successful  intravenous  therapy  with  the  homologous 
(rabbit)  {mrnune  serum  as  contrasted  to  entirely  negative  results 
with the homologous normal serum.  The injection of normal rabbit 
serum appears to have no effect upon the number of circulating or- 
ganisms. 
These results show that the non-specific element involved in specific 
intravenous therapy with "raw" serum must be considered as a definite 
factor but negligible as compared to the specific element and probably 
having no bearing on the outcome of any case. 
rrr. 
Active Immunity. 
In our previous  communication (1)  the  relation  of  crisis  to  the 
development of active immunity in the experimental rabbit  disease 
was discussed.  In the following paragraphs we propose to present 
observations  concerning active  immunity  in  convalescent  animals 
and in those previously vaccinated,  and to  discuss the problem of 
active immunization in pneumonia. 
The Determination of Active Immunity.--Our experience leads us to 
believe that for the present the only reliable method of determining 
active immunity is  by observing the response to  reinfection.  Pre- 
liminary  experiments  showed  that  convalescent  rabbits,  though 
immune, still develop a  limited localized lesion at the site of intra- 
dermal inoculation of undiluted virulent pneumococcus broth culture, 
and for this reason, before an arbitrary reinfection dose could be se- 
lected,  it was necessary to  study the results obtained with varying 
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The method of carrying out this experiment differed from that used 
in  determining  the  susceptibility  of  the  normal  rabbit  to  varying 
intradermal  dosage of pneumococci, for in the convalescent case the 
lesion obtained does not  exhibit the tendency to  spread that  is  seen 
in the normal animal.  A  number of tests may therefore be made on 
a  single animal at the same time.  The results of such an experiment 
are shown in Table II. 
On the basis of this experiment it seemed that  there would be  no 
particular advantage attached to the use of any one dose for reinfec- 
TABLE II. 
Susceptibility of the "Immune" Rabbit to Varying Dosage of Pneumococci. 
Rabbit 4-28; 22 days convalescent.  Entire abdominal area shaved, and vary- 
ing amounts of culture, diluted to 0.2  cc.  in broth, injected intradermally in 
various separated areas. 
Amount of  Reading at 24 hrs.  Area  broth culture 
CC. 
0.2 
0.04 
0.01 
0.002 
0.001 
Local lesion with definite color and edema; no tendency to 
spread 
As above 
Local area of heightened  color; no swelling 
Trace of color  at point of inoculation; no swelling 
Very slightest trace  of color at point of inoculation; no 
swelling 
With amounts below those given, no sign of inflammation was observed 
tion except that with the larger amounts the local lesion would amply 
safeguard  the  fact that  virulent  organisms  had  been  injected.  We 
have therefore used  0.2  cc.  of undiluted  18-hour broth  culture  as  a 
routine.  This is injected, as in cases described in our previous paper, 
well up on the animal's side.  Observations as to the character of the 
lesion  and  the  animal's  temperature  are  made  at  24  hours.  Blood 
cultures are not done unless the lesion is widespread, for in our experi- 
ence the local type of lesion is associated with entirely negative blood 
cultures. 
The resistance to infection has been studied by this method in over 
50  cases.  The  results  show  some  variation  but  each  case  falls  dis- KENNETH  G00D1VER  423 
tinctly into one of the divisions of a classification that has been devised 
and is shown in Table III.  This classification is based on the type of 
immune  reaction  previously  described  for  untreated  convalescent 
cases and upon the assumption that the normal rabbit has no immunity 
against the pneumococcus. 
The first  class  shown in Table III represents the normal rabbit, 
which has no immunity against intradermal pneumococcic infection 
and which after infection undergoes the type of disease that we have 
described in  detail in the previous paper. 
Classes 2 and 3 represent those cases which are spoken of as possess- 
ing  partial  immunity.  The  lesions  in  these  cases  are  practically 
TABLE  III. 
Classification of Results in Observations on Active Immunity. 
Class 
Designa- 
tion of 
immunity  Area of lesion 
--  Widespread 
+  Widespread 
+  +  Widespread 
+++  Local 
+++'4-  No  lesion  or 
sign of 
lesion 
Readings at 24 hrs. 
Temperature 
High 
Moderate  (less  than 
105.00) 
Low (less than 104.0 °  ) 
Little  or  no  elevation 
of temperature 
No change in tempera- 
ture 
Coupe 
Typical  febrile 5-  to  7-day 
course 
Typical  course  except  less 
severe 
Short and mild course 
Lesion begins to  subside in 
36 to 48 hrs. 
indistinguishable from those in Class 1, but there is a significant lack 
of severity in the temperature reaction and other objective symptoms. 
Class  4  has  already been  described.  It  represents the  ordinary 
maximal immunity observed following an attack of the disease.  It 
therefore probably is  comparable to  absolute natural immunity. 
Into the fifth class fall those animals which have  been immunized 
by a course of injections of dead pneumococci; that have built up a 
high antibody content and may be conveniently referred to as hyper- 
immune. 
Active Immunity Following Recovery without Treatment.--Since  only 
a small proportion of untreated cases survive an attack of the experi- 424  INTRADF.R~IAL PIWEL~IOCOCCUS INFECTION 
mental disease, it has not been possible to study some features of the 
acquired immunity in  the greatest detail.  It has been  determined 
that a definite (+ + +) immunity is acquired and that this immunity 
persists at a high level for several months.  In one case it persisted 
for 9 months but in two other instances the immunity was not main- 
tained for this length of time.  In one case in a series of ten, partial 
immunity only was observed at the end of the 2nd month.  We hope 
to  determine the limits of efficiency of  this  acquired immunity in 
future experiments.  For the present no absolute conclusion is  justi- 
fied except that the immunity acquired seems to persist for  several 
months but is not permanent. 
A6tlve Immunity in Treated Cases.--In  repeated instances we have 
determined that if a rabbit subjected to dermal inoculation is treated 
within 24 hours with an effective  dose of heterologous  serum it promptly 
recovers but after the passive immunity has worn off, such an animal 
possesses no active immunity against subsequent infection.  We have 
reinfected rabbits of this type at from 15 to 60 days following original 
infection and  in no case have we observed more than a  "one-plus" 
immunity.  In several cases the immunity was entirely negative. 
If treatment is delayed until the 48th or 50th hour it does not appear 
to interfere with the development of active immunity, for such cases 
show the characteristic "three-plus" immunity after recovery. 
This  same principle  has  been  demonstrated in  animals  given  a 
single  vaccination  of  washed  heat-killed pneumococci.  No active 
immunity develops in such cases if they are given,  within 24 hours 
after vaccination,  an  amount of heterologous immune serum corre- 
sponding to an effective dose for that hour. 
It has been suggested that this arrest of developing immunity may 
be concerned with the lack of immunizing power of the substances 
resulting from the proteolytic digestion of the phagocyted bacteria. 
It seems certain that the phagocytic activity of circulating leucocytes 
is increased by the agency of the immune serum and in the case of 
early treatment it might be reasoned that the bacteria or their anti- 
genic fractions do not reach the tissues in form suitable for stimulat- 
ing antibody production. 
If cases are treated with heterologous immune serum in amounts 
insufficient  to  produce  therapeutic  effect  (subeffective)  a  certain KENNETH  G00DNER  425 
number of animals recover spontaneously after a  typical and severe 
course.  In these instances the introduction of subeffective amounts 
of serum had not interfered with the development of immunity and 
these cases show the same immune character as do the untreated cases. 
If an homologous antipneumococcic serum is used for arresting the 
course  of the  disease,  and  the  rabbits  are  subsequently tested for 
immunity, the results differ from those obtained when heterologous 
serum is used.  These animals, treated with the homologous serum, 
show a definite (-b -b +) immunity following recovery.  This immun- 
ity persists certainly for over a month at a high level and in one case a 
slight immunity (+) remained at 9 months.  At this time there is no 
method by which it can be determined whether this result is due to an 
active immunity or to  a  prolonged and effective passive immunity. 
In this connection it is of interest to recall that Park (5) has reported 
a  similar finding as regards diphtheria antitoxin, for he found that a 
guinea pig receiving 10 units of diphtheria antitoxin prepared in an 
immunized guinea pig  remained immune for  from  6  to  8  months, 
while a guinea pig receiving 10 units of antitoxin made in an immun- 
ized horse, remained immune for only 2 or 3  weeks. 
Active Immunity and Agglutinins.--In  twenty-eight cases of com- 
plete immunity to reinfection we have observed circulating aggluti- 
nins in about half.  Partiallylmmune animals have also been observed 
to show circulating agglutinins, even in as high a titer as 1-40.  It is 
not easy to appraise the significance of these results, which however 
indicate quite clearly that the absence of circulating agglutinins does 
not signify the lack of immunity, and conversely it is also probable 
that the presence of circulating agglutinins does not indicate that the 
animal is  completely resistant to infection. 
Active Immunity and the Mouse-Protective Value of the Serum.--In 
a series of some twenty-five recovered rabbits we have correlated the 
immunity against infection with the protective value for mice of serum 
taken at that time.  Animals whose sera are protective have always 
shown some degree of immunity to infection and in most instances 
this immunity is complete.  Animals which are entirely non-resistant 
to infection show no protective substance but it is also true that some 
rabbits  which are  completely immune may possess  serum with  no 
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From the protective property alone, no conclusion is justified as to 
the  immunity possessed by  the  animal.  There  remains  only  one 
method of testing the immunity of the experimental animal and that 
is to  reinfect it. 
Active  Immunity  after Vaccination  with  Killed  Pneumococci.--It 
has been stated above that  the  "hyperimmunized"  rabbits  usually 
show a  complete immunity (++++)  against infection if such a test 
is carried out during the time that the antibody titer is high. 
In our preceding paper we had occasion to use single vaccination 
as  a  means of studying the possible significance of the crisis.  The 
knowledge that  a  single vaccination gave  rise  within 5  days to  an 
immunity sufficient to protect an animal against infection has con- 
tinued to interest us in its possible application to the disease in man. 
For this reason we have begun to  study the immunity acquired in 
rabbits as a result of a single vaccination with heat-killed pneumococci. 
For routine intravenous vaccination we have used 10 cc. of a suspen- 
sion, of washed heat-killed pneumococci, the density of which was 
1.2 cm. (as measured by the method of Gates  (6)).  This is an ex- 
tremely heavy suspension. 
If the vaccinated rabbits are tested at 5 days by the usual method 
of intradermal inoculation of 0.2 cc. of undiluted broth culture, a three- 
or four-plus immunity is observed, in that respect being quite analo- 
gous to the convalescent case.  In another sense the one-vaccination 
animal is unlike the convalescent for its acquired immunity wears off 
somewhat more quickly.  In only one instance, of eight cases,  did it 
persist in maximum degree for as long as 2 months. 
The development of protective substances (for mice) in the rabbit 
has been quite thoroughly studied by Armstrong (7).  In many of 
his  experiments he observed a  rise of protective substances within 
3  to  5  days after  a  single injection of pneumococcus vaccine.  We 
have confirmed  that result.  In Armstrong's series there was a gradual 
drop of circulating protective substances in from 8  days to  several 
weeks; these intervals he held to  be  somewhat proportional to  the 
amount of vaccine used.  In our experiments this drop of protective 
substances  has  been  irregular  and  apparently  independent of  the 
dosage. 
The development of protective substances and immunity during a KENNETH  GOODNER  427 
period of 5 or 6 days following vaccination seems to be a characteristic 
of the pneumococcus rather than of the species of the animal used. 
We have found that mice develop an active immunity against infec- 
tion within 4 or 5 days after a  single injection of vaccine and this is 
possibly the fundamental reason that makes it unnecessary to observe 
mice in protection experiments for longer than that period of time. 
Through the kindness of Drs. White and Robinson of the Massachu- 
setts Antitoxin and Vaccine Laboratory it has been possible to study 
the  development of  protective  substances  in  horses  after  a  single 
injection of heat-killed pneumococci.  The sera of these horses were 
not examined on the 5th day but on the 6th protective substances 
were found in each of two cases.  The crisis in human lobar pneumonia 
at 5 to 7 days must also be correlated with this characteristic period 
of time. 
The Possible Application  of These Findings.--In the foregoing para- 
graphs  it  has  been  established  that,  in  rabbits,  active  immunity, 
whether acquired in  disease or artificially by vaccination, is not of 
exceedingly long duration,  and  even  at  its  height  is  unable  in  all 
cases effectively to overcome overwhelming doses of organisms imme- 
diately (the typical three-plus immunity).  These facts are comparable 
to  the present theories regarding active immunity in  human lobar 
pneumonia. 
There have been attempts, especially by Lister (8),  and by Cecil 
and Austin (9), to use vaccination as a means of prophylaxis.  Consid- 
ering the difficulties in the preparation of a  polyvalent vaccine and 
the apparently low antigenic properties of Type in, the results re- 
ported by these workers were very encouraging. 
Although our experiments have been entirely with Type I and with 
experimental  animals,  it  would seem that  if  vaccination  could  be 
applied in a systematic way to a susceptible population throughout the 
"pneumonia season" it should yield results.  In such an application 
the  two  factors  that  must  be  especially  considered  are  (a)  the 
polyvalent  character  of  the  vaccine  and  (b)  the  shortness  of  the 
immune phase conferred by vaccination.  It would seem possible to 
rule out the second point by the use of single subcutaneous injections 
of vaccine at  1- or 2-month intervals during the season  of  highest 
pneumonia morbidity. 428  INTRADERMAL PNEUMOCOCCUS  INFECTION 
S~ARY. 
I.  The continuation of our experiments with intradermal Type I 
pneumococcus infection in rabbits has furnished further evidence of 
the marked analogies between this condition and that of human lobar 
pneumonia. 
2.  It has been found that the amount of antiserum necessary for 
successful therapy increases as the disease progresses,  and that this 
progression has a definite mathematical character.  Such a condition, 
it seems, can only be caused by a  progressive accumulation of some 
toxic or antagonistic substance, the exact nature of which is not known. 
3.  Various lots of antipneumococcus sera have been tested for their 
therapeutic properties.  The results from seven such sera show that 
this therapeutic value does not parallel the mouse-protective value. 
It is suggested that the rabbit technic may prove useful for the rou- 
tine comparison and standardization of antipneumococcus sera since 
it represents a simple method for determining that property for which 
the serum is to be utilized. 
4.  The effect of non-specific therapy in this condition has been de- 
termined to  be  a  transient  disappearance from the blood stream of 
circulating organisms.  This result was obtained with such heterolo- 
gous materials as normal horse serum and typhoid vaccine but  not 
with the homologous normal rabbit serum. 
5.  Rabbits  recovering from the intradermal disease without treat- 
ment or with such inadequate treatment that the disease runs its nor- 
mal  course,  were  shown  to  have  a  definite though not  permanent 
immunity.  Cases in which the disease had been arrested at 24 hours 
by  effective therapy  with  heterologous immune  serum  showed  no 
immunity after the early disappearance of the passively administered 
elements.  Cases which were brought to early recovery with immune 
homologous serum did show a  definite immunity comparable to that 
which was developed in other animals as the result of an untreated 
course of the disease. 
6.  The immunity conferred by single and multiple vaccination is 
reported.  The possibility of the application of such methods in the 
pneumonias of man is discussed and a method for such an application 
is suggested. KENNETH  GOODNER  429 
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